Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice

Toxicology Letters

Volumn 223, Issue 2, 2013, Pages 146-153

  Chen, Tian ^a   Jia, Guang ^a   Wei, Yongjie ^b,c   Li, Jiucun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE RESEARCH ACADEMY OF ENVIRONMENTAL SCIENCES   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Ambient particle; ApoE knockout mice; Atherosclerosis; Lipid metabolism; Oxidative stress; Systemic inflammation

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CHOLESTEROL; COAL; DIESEL FUEL; GASOLINE; LOW DENSITY LIPOPROTEIN; NATURAL GAS; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOMASS; BLOOD SAMPLING; CHINA; CHOLESTEROL BLOOD LEVEL; COOKING; ENVIRONMENTAL EXPOSURE; LIPID METABOLISM; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL;

AMBIENT PARTICLE; APOE KNOCKOUT MICE; ATHEROSCLEROSIS; LIPID METABOLISM; OXIDATIVE STRESS; SYSTEMIC INFLAMMATION;

AIR POLLUTION; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CITIES; DISEASE MODELS, ANIMAL; INFLAMMATION; INHALATION EXPOSURE; INTERLEUKIN-6; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PARTICLE SIZE; PARTICULATE MATTER; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VEHICLE EMISSIONS;

EID: 84886238870     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.09.004     Document Type: Article

References (49)

1. Allen R.W., Criqui M.H., Roux A.V.D., Allison M., Shea S., Detrano R., Sheppard L., Wong N.D., Stukovsky K.H., Kaufman J.D. Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology 2009, 20:254-264.
2. Araujo J.A., Barajas B., Kleinman M., Wang X.P., Bennett B.J., Gong K.W., Navab M., Harkema J., Sioutas C., Lusis A.J., Nel A.E. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ. Res. 2008, 102:589-596.
3. Araujo J.A., Nel A.E. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part. Fibre Toxicol. 2009, 6:24.
4. Barter P.J., Nicholls S., Rye K.A., Anantharamaiah G.M., Navab M., Fogelman A.M. Antiinflammatory properties of HDL. Circ. Res. 2004, 95:764-772.
5. Bauer M., Moebus S., Mohlenkamp S., Dragano N., Nonnemacher M., Fuchsluger M., Kessler C., Jakobs H., Memmesheimer M., Erbel R., Jockel K.H., Hoffmann B., HNR Study Investigative Group. Urban particulate matter air pollution is associated with subclinical atherosclerosis results from the HNR (Heinz Nixdorf Recall) study. J. Am. Coll. Cardiol. 2010, 56:1803-1808.
6. Brook R.D., Rajagopalan S., Pope C.A., Brook J.R., Bhatnagar A., Diez-Roux A.V., Holguin F., Hong Y.L., Luepker R.V., Mittleman M.A., Peters A., Siscovick D., Smith S.C., Whitsel L., Kaufman J.D., American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, Council on Nutrition, Physical Activity and Metabolism Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378.
7. Chan C.K., Yao X. Air pollution in mega cities in China. Atmos. Environ. 2008, 42:1-42.
8. Chen L.C., Nadziejko C. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice: V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhal. Toxicol. 2005, 17:217-224.
9. Chuang K.J., Yan Y.H., Cheng T.J. Effect of air pollution on blood pressure, blood lipids, and blood sugar: a population-based approach. J. Occup. Environ. Med. 2010, 52:258-262.
10. Duan F.K., He K.B., Ma Y.L., Yang F.M., Yu X.C., Cadle S.H., Chan T., Mulawa P.A. Concentration and chemical characteristics of PM2.5 in Beijing, China: 2001-2002. Sci. Total Environ. 2006, 355:264-275.
11. Duan J.C., Tan J.H., Wang S.L., Hao J.M., Chail F.H. Size distributions and sources of elements in particulate matter at curbside, urban and rural sites in Beijing. J. Environ. Sci. China 2012, 24:87-94.
12. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., Wagner A.E., Frank J., Schrezenmeir J., Rimbach G., Wolffram S., Muller M.J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102:1065-1074.
13. Gan L.M., Gronros J., Hagg U., Wikstrom J., Theodoropoulos C., Friberg P., Fritsche-Danielson R. Non-invasive real-time imaging of atherosclerosis in mice using ultrasound biomicroscopy. Atherosclerosis 2007, 190:313-320.
14. Gofman J.W., Jones H.B., Lindgren F.T., Lyon T.P., Elliott H.A., Strisower B. Blood lipids and human atherosclerosis. Circulation 1950, 2:161-178.
15. Hoffmann B., Moebus S., Kroger K., Stang A., Mohlenkamp S., Dragano N., Schmermund A., Memmesheimer M., Erbel R., Jockel K.H. Residential exposure to urban air pollution, ankle-brachial index, and peripheral arterial disease. Epidemiology 2009, 20:280-288.
16. Hoffmann B., Moebus S., Mohlenkamp S., Stang A., Lehmann N., Dragano N., Schmermund A., Memmesheimer M., Mann K., Erbel R., Jockel K.H. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation 2007, 116:489-496.
17. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2001, 21:844-848.
18. Holvoet P., Van Cleemput J., Collen D., Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20:698-702.
19. Jacobs L., Emmerechts J., Hoylaerts M.F., Mathieu C., Hoet P.H., Nemery B., Nawrot T.S. Traffic air pollution and oxidized LDL. PLoS One 2011, 6:e16200.
20. Kunzli N., Jerrett M., Mack W.J., Beckerman B., LaBree L., Gilliland F., Thomas D., Peters J., Hodis H.N. Ambient air pollution and atherosclerosis in Los Angeles. Environ. Health Perspect. 2005, 113:201-206.
21. Kunzli N., Perez L., von Klot S., Baldassarre D., Bauer M., Basagana X., Breton C., Dratva J., Elosua R., de Faire U., Fuks K., de Groot E., Marrugat J., Penell J., Seissler J., Peters A., Hoffmann B. Investigating air pollution and atherosclerosis in humans: concepts and outlook. Prog. Cardiovasc. Dis. 2011, 53:334-343.
22. Li N., Alam J., Venkatesan M.I., Eiguren-Fernandez A., Schmitz D., Di Stefano E., Slaughter N., Killeen E., Wang X.R., Huang A., Wang M.Y., Miguel A.H., Cho A., Sioutas C., Nel A.E. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol. 2004, 173:3467-3481.
23. Li R., Navab M., Pakbin P., Ning Z., Navab K., Hough G., Morgan T.E., Finch C.E., Araujo J.A., Fogelman A.M., Sioutas C., Hsiai T. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J. Lipid Res. 2013, 54:1608-1615.
24. Mehra V.C., Ramgolam V.S., Bender J.R. Cytokines and cardiovascular disease. J. Leukoc. Biol. 2005, 78:805-818.
25. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994, 14:133-140.
26. Pope C.A. Particulate air pollution, C-reactive protein, and cardiac risk. Eur. Heart J. 2001, 22:1149-1150.
27. Pope C.A., Dockery D.W. Health effects of fine particulate air pollution: lines that connect. J. Air Waste Manage. Assoc. 2006, 56:709-742.
28. Rice M.B., Cavallari J., Fang S.N., Christiani D. Acute decrease in HDL cholesterol associated with exposure to welding fumes. J. Occup. Environ. Med. 2011, 53:17-21.
29. Roux A.V.D., Auchincloss A.H., Franklin T.G., Raghunathan T., Barr R.G., Kaufman J., Astor B., Keeler J. Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 2008, 167:667-675.
30. Shang Y., Sun Z.W., Cao J.J., Wang X.M., Zhong L.J., Bi X.H., Li H., Liu W.X., Zhu T., Huang W. Systematic review of Chinese studies of short-term exposure to air pollution and daily mortality. Environ. Int. 2013, 54:100-111.
31. Simkhovich B.Z., Kleinman M.T., Kloner R.A. Air pollution and cardiovascular injury. J. Am. Coll. Cardiol. 2008, 52:719-726.
32. Skalen K., Gustafsson M., Rydberg E.K., Hulten L.M., Wiklund O., Innerarity T.L., Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750-754.
33. Soares S.R.C., Carvalho-Oliveira R., Ramos-Sanchez E., Catanozi S., da Silva L.F.F., Mauad T., Gidlund M., Goto H., Garcia M.L.B. Air pollution and antibodies against modified lipoproteins are associated with atherosclerosis and vascular remodeling in hyperlipemic mice. Atherosclerosis 2009, 207:368-373.
34. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T-lymphocytes from human atherosclerotic plaques recognize oxidized low-density-lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:3893-3897.
35. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004, 84:1381-1478.
36. Sun Q.H., Wang A.X., Jin X.M., Natanzon A., Duquaine D., Brook R.D., Aguinaldo J.G.S., Fayad Z.A., Fuster V., Lippmann M., Chen L.C., Rajagopalan S. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. J. Am. Med. Assoc. 2005, 294:3003-3010.
37. Sun Y.L., Zhuang G.S., Ying W., Han L.H., Guo J.H., Mo D., Zhang W.J., Wang Z.F., Hao Z.P. The air-borne particulate pollution in Beijing - concentration, composition, distribution and sources. Atmos. Environ. 2004, 38:5991-6004.
38. Tani S., Dimayuga P.C., Anazawa T., Chyu K.Y., Li H.Y., Shah P.K., Cercek B. Aberrant antibody responses to oxidized LDL and increased intimal thickening in apoE-/- mice exposed to cigarette smoke. Atherosclerosis 2004, 175:7-14.
39. Tomao E., Tiziana P.B., Rosati V., Marcellini L., Tomei F. The effects of air pollution on the lipid balance of traffic police personnel. Ann. Saudi Med. 2002, 22:287-290.
40. Toshima S., Hasegawa A., Kurabayashi M., Itabe H., Takano T., Sugano J., Shimamura K., Kimura J., Michishita I., Suzuki T., Nagai R. Circulating oxidized low density lipoprotein levels - a biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2243-2247.
41. Wallenfeldt K., Fagerberg B., Wikstrand J., Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J. Intern. Med. 2004, 256:413-420.
42. Watson J.G., Fujita E.M., Chow J.C., Pace T.G., Lewis C., Coulter T. CMB8 Applications and validation protocol for PM2.5 and VOCs. Desert Research Institute Document No 18082D1, Reno, NV 1998.
43. Wei Y.J., Han I.K., Hu M., Shao M., Zhang J.F., Tang X. Personal exposure to particulate PAHs and anthraquinone and oxidative DNA damages in humans. Chemosphere 2010, 81:1280-1285.
44. Wei Y.J., Han I.K., Shao M., Hu M., Zhang J.F., Tang X.Y. PM2.5 constituents and oxidative DNA damage in humans. Environ. Sci. Technol. 2009, 43:4757-4762.
45. Whitman S.C. A practical approach to using mice in atherosclerosis research. Clin. Biochem. Rev. 2004, 25:13.
46. Yeatts K., Svendsen E., Creason J., Alexis N., Herbst M., Scott J., Kupper L., Williams R., Neas L., Cascio W., Devlin R.B., Peden D.B. Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma. Environ. Health Perspect. 2007, 115:709-714.
47. Ylaherttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., Witztum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 1994, 14:32-40.
48. Zhang Y.Z., Zanotti I., Reilly M.P., Glick J.M., Rothblat G.H., Rader D.J. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003, 108:661-663.
49. Zheng M., Salmon L.G., Schauer J.J., Zeng L.M., Kiang C.S., Zhang Y.H., Cass G.R. Seasonal trends in PM2.5 source contributions in Beijing, China. Atmos. Environ. 2005, 39:3967-3976.